To open research week experts from across the CMCVAMC departments were brought together to give updates on their progress and work, and to acknowledge Dr. Pierre Conti and Dr. Dave Oslin for their distinguished work.

The Jonathan and Plum Simons Prostate Cancer Center of Excellence was established at the CMCVAMC in 2019 with support from the Prostate Cancer Foundation.

While antimalarial resistant discoid lupus leads to extremely poor quality of life, there is not a good understanding of how it differs from antimalarial responsive lupus on a cellular level.

While reduced sleep and sleep disturbances are characteristics of depression, a common issue with the veteran population, data on individuals’ sleep is rarely obtained and used to determine clinical treatment and outcomes.

While the suicide rate among women Veterans is increasing, the unique characteristics associated with suicide risk among women veterans are currently not well understood.

Racial and ethnic disparities have been robustly found within healthcare, but whether these disparities exist within end-of-life care is not currently understood.

Rodents with traumatic muscle loss had artificially grown tissue (InTEM) implanted.

NeuroFlow, a mental health technology company, has been awarded a $225,000 Phase I Small Business Technology Transfer (STTR) grant from the National Science Foundation to implement its flagship software product EngageBH at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, PA.

To understand overall health outcomes a holistic perspective is needed that recognizes access to safe housing, nutritious food, reliable transportation, clean water, employment and social connectedness all play a role.

Dr. David Oslin, a researcher at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, is testing the use of genetic information to tailor drug therapies for Veterans with major depression.